Home
Categories
Ingredients
Research & Development
Manufacturing
Packaging
Company News
Active Nutrition
Cardiovascular
Digestion
Cognitive
Finance
Regulatory
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Open Book Extracts
Open Book Extracts
Activities:
Ingredients
Trending Articles
DolCas expands Curcugen into functional honey and cognitive beverage
DolCas Biotech is extending its full-spectrum curcumin ingredient into Mānukora’s Mānuka honey blend and Numin’s decision-fatigue beverage, targeting new delivery formats...
FDA establishes new regulation permitting Lallemand's Vitamin D₂ Inactive Bakers Yeast in multiple food categories in the United States
Lallemand is pleased to announce that the U.S. Food and Drug Administration (FDA) has amended its food additive regulations to permit the use of Vitamin D₂ Inactive Bakers...
ADM to showcase nutrition and reformulation solutions at Fi Europe 2026
ADM will present innovations spanning sugar reduction, plant-based proteins, biotics and personalised nutrition at Fi Europe 2026, alongside regenerative agriculture...
Seppic to showcase NAD+ and GLP-1 hair support at SupplySide Global 2026
Garden of Time showcases science-backed ingredients for longevity, cellular health, skin and hair support, and cognitive health at Booth #6181
Ourvita to spotlight ‘Metabolic Resilience’ at SupplySide Global 2026
In the GLP-1 era, discover how Ourvita is looking well beyond weight with four ready-to-go, science-led concepts spanning gut health, performance and more, plus the debut of...
Upcoming event
Nutrients 2026 – Clinical Nutrition: from Research to Practice
22-24 October 2026 | Conference | Barcelona
See all
Related Content
Ingredients
Open Book Extracts (OBX) announces founding membership in ONE HEMP
Since the inception of Open Book Extracts (OBX) in 2019, the company has served as a leader in the hemp-based CBD market, prioritising science, safety, and responsible commerce
Ingredients
OBX launches trial for minor cannabinoid formulations
The cannabinoids selected were CBD, CBG, CBC, and CBDV, and the polyphenols selected were Quercetin and Curcumin
Finance
OBX receives strategic investment from Btomorrow Ventures
The two companies have signed a scientific collaboration agreement covering areas of future R&D
Ingredients
Open Book Extracts expands capabilities and management team to boost finished goods manufacturing
The expansion will serve to address increased demand for the company’s product development and manufacturing services
Regulatory
OBX announces results of Phase I toxicology assessment
The company contracted AIBMR Life Sciences to conduct the studies investigating the safety of consuming its CBG, CBN, and CBC products
Ingredients
OBX completes trial of cannabinoids for pain relief
Results from the pain study are expected in late April 2022 and will be announced at that time
Ingredients
Open Book Extracts appoints European sales leadership
In March 2021, OBX became a member of the European Industrial Hemp Association Novel Food Consortium
Subscribe now